Status:
COMPLETED
Kenya: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum Hemorrhage
Lead Sponsor:
PATH
Collaborating Sponsors:
Department for International Development, United Kingdom
University of Nairobi
Conditions:
Postpartum Hemorrhage
Eligibility:
All Genders
22+ years
Brief Summary
The purpose of this implementation research study is to generate evidence that informs the successful uptake and adoption of the Ellavi Uterine Balloon Tamponade (UBT) within Kenyan postpartum hemorrh...
Detailed Description
The purpose of this implementation research study is to generate evidence that informs the successful uptake and adoption of the Ellavi UBT within Kenyan MOH PPH management programs for both public an...
Eligibility Criteria
Inclusion
- Obstetricians, medical officers, clinical officers, and midwives who recently participated in a PPH/Ellavi UBT training or managed a refractory PPH case (with or without the use of an Ellavi UBT (within the past 72 hours) at one of the 3 participating health care facilities.
- Hospital administrators, supply store managers and/or procurement staff
Exclusion
- \- Obstetricians, medical officers, clinical officers, and midwives working at the facility who do not agree or consent to participate.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04502173
Start Date
December 1 2020
End Date
December 30 2021
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kenyatta National Hospital
Nairobi, Kenya